The label-free Octet K2 Biolayer Interferometer is your entry-level system to the automated measurement of molecular interactions at moderate throughput.
Its patented 2-channel design allows you to measure 2 samples in parallel and thus to save time. Quickly and easily characterize protein-protein or protein-small molecule interactions, determine affinity or simply the concentration of active analytes.
The microfluidic-free Dip-and-Read™ format combines the measurement of unpurified mixtures directly in standardized microplates. The flexibility with regards to sample types ranges from molecules sized only 150 Da to viruses or whole human cells.
After measurement, the samples can be used for further processing steps or analyses.
The biosensors can be regenerated and reused when the experiment is over. This reduces your operating costs for consumables.
Increase the efficiency and quality of your research with the Octet K2 Biolayer Interferometer.
Full power across 8 channels: Label-free and GxP-compliant analysis of molecular interactions
Biolayer interferometer system ✓ 8-channel measurement ✓ Active temperature control ✓ Protein-protein interaction assay ✓ Fully automated ✓ GxP compliant ✓ more
Characterize and Quantify Proteins with Only a Single Droplet
Biolayer interferometer system ✓ Minimal space required ✓ Only 4 µL of sample ✓ Protein quantification ✓ Protein kinetics ✓ Protein-protein interactions ✓ more
No need for process delays due to protein analysis: Quantify 96 samples in 2 minutes
Bio-layer interferometer system ✓ High-throughput – 96 biosensors ✓ Protein quantification ✓ Assay for protein-protein interactions ✓ Fully automated ✓ more
Sartorius closes 2020 with strong growth
Sartorius recorded high growth according to preliminary figures in 2020 due to strong organic development, several acquisitions and the additional momentum from business related to the coronavirus pandemic. The Group closed the year with significant double-digit growth rates in sales revenu ... more
Strong profitable growth at Sartorius
Sartorius closed the first nine months of 2020 with significant double-digit growth rates in sales revenue and earnings. “In the third quarter, we saw high demand for nearly our entire product range,” said Joachim Kreuzburg, CEO. “On top of overall strong organic growth, additional momentum ... more
Purification specialist BIA Separations to become part of Sartorius
Sartorius announced it has entered into a definitive agreement to merge purification specialist BIA Separations into its subgroup Sartorius Stedim Biotech in a transaction totaling 360 million euros of which 240 million euros will be paid in cash and 120 million euros in Sartorius Stedim Bi ... more
